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1998. Pp. 235. £7.99 (paper).
The product of a large and multifaceted committee, this ex-
cellent compendium provides no quick or easy answers. The
British Medical Association (BMA) assembled a 17-member
Steering Group to produce this guide to virtually any ethical
problem that might present itself in medical genetics. These
editors include the Bishop of Edinburgh, several geneticists and
general practitioners, a genetic counselor, a consumer advo-
cate, a social scientist, and two bioethicists. The book’s great
strengths are its balanced, even tone, its comprehensive ap-
proach, and its accessibility. Although aimed at health pro-
fessionals—including general practitioners and nurses, as well
as genetics specialists—it is purposely couched in terms un-
derstandable to laypeople, and so it avoids both biomedical
jargon and the specialized terminology of academic philo-
sophy.
The volume opens with brief definitions of harms, benefits,
and disability, followed by a discussion of commonly held
ethical principles that is presented in terms comprehensible to
laypeople. A 10-page chapter on basic genetics follows. Suc-
ceeding chapters deal with prenatal diagnosis and screening
and their societal implications, eugenics and respect for people
with disabilities, carrier testing, presymptomatic testing, test-
ing children, adoption, population screening, newborn screen-
ing, nondirectiveness in counseling, medical and social uses
and misuses of genetic information, paternity testing, forensics,
and gene therapy. A brief 7-page section deals with regulations,
both in the United Kingdom and internationally. Summary
statements are boxed for ease in skimming. Each chapter also
includes a comprehensive, but not overwhelming, list of refer-
ences.
Throughout the book, the editors’ stated intentions are to
present all reasonable sides of an issue, taking a definite stance
only when the BMA has already taken a policy position on a
related issue, or when other bodies—such as the Nuffield
Council on Bioethics or the House of Commons Science and
Technology Committee—have presented recommendations.
The editors have done an excellent job of foreseeing the dif-
ferent possibilities and pitfalls in each situation, including
many that may not seem immediately obvious. Their funda-
mental principle, which is shared by most American medical
ethicists, is individual autonomy, but they acknowledge that
individual rights are not absolute. They recognize the need for
mutuality, especially toward family members who may be able
to use genetic information about an individual to prevent harm
to others. With admirable common sense, the editors note that
the family is more likely than government or employers to seek
an individual’s genetic information. BMA recommendations
for overriding confidentiality are similar to those of the
ASHG’s statement on Professional Disclosure of Familial Ge-
netic Information (1998), but include considerations of the
emotional effects of receiving unexpected, and possibly un-
wanted, information. Here, as elsewhere, the editors avoid
proposing strict rules.
In general, the book takes the view that the embryo and
fetus deserve some, but not absolute, respect. Although the
BMA argues throughout this book that “enhancing individual
choice rather than directive encouragement towards termina-
tion of an affected pregnancy must be seen as the principal
objective” of prenatal diagnosis (PND) (p. 48), the editors
recognize that many members of the British medical profession
espouse more “preventive” views. Indeed, they point out a
1993 survey that found that one-third of British obstetricians
require patients to commit to abortion before the procedure.
The arguments recognize, with considerable sensitivity, the
viewpoints of the disabled community, while balancing these
viewpoints against families’ rights to choose. The positions of
the Genetic Interest Group (GIG), the United Kingdom’s um-
brella organization for genetic support groups, are represented
throughout. The editors warn against discrimination against
“expensive” or “uneconomic” patients, and they reject sex
selection as a goal of medical intervention, regardless of
whether the technique in question operates during the pre-
conception, preimplantation, or prenatal period. Like many
projects of this sort, this document does not define the “se-
rious” disorders for which PND is ethically permissible or the
“trivial” pursuits that should be kept outside presumed bound-
aries. Such definitions are perhaps impossible.
Unlike most discussions of PND in the United States, this
book recommends caution in the use of PND procedures for
adult-onset disorders, partly because if the fetus is carried to
term, the resulting child will have received a presymptomatic
test without consent. In a typical compromise position, the
editors express concern about routine use, but agree that in
some circumstances testing is appropriate. A balanced discus-
sion of the issue leads them to discourage the testing of minors
for carrier status or for disorders that occur later in life, but
they urge a flexible approach that acknowledges the benefits,
to both child and family, of testing in some cases.
The report leaves the door open to future attempts at germ-
line gene therapy, provided that it is first proven safe and
efficacious. Although all agree that there is still insufficient
knowledge to evaluate risks and that, therefore, human re-
search should not be undertaken, philosopher John Harris, a
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member of the Project Steering Committee, argues that, in the
future, there could actually be an ethical obligation to use
germline therapy under the principle of avoiding harm.
The panel rejected all forms of human cloning, including
splitting of embryos in in vitro fertilization, that would pro-
duce “identical” siblings, on the basis that, at present, the
possible harms appear to outweigh the benefits. The report
urges caution about premature legislation, however, and
quotes a House of Commons report on the cloning of animals,
to the effect that it is important to “keep such matters under
review, as science develops and public attitudes shift, since it
is possible, as in other areas of science and medicine, that
developments which were originally considered objectionable
may come to seem routine.”
This compact paperback could serve as an excellent text for
medical school courses in human genetics, especially since
boxed summaries and brief sections of individual chapters
could be pulled out for discussion. The book could also be
useful for both general practitioners and experienced geneti-
cists around the world, since it touches on most issues in clin-
ical practice.
DOROTHY C. WERTZ
Social Science, Ethics, and Law
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